BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18449015)

  • 1. Pulmonary epithelioid haemangioendothelioma and bevacizumab.
    Belmont L; Zemoura L; Couderc LJ
    J Thorac Oncol; 2008 May; 3(5):557-8. PubMed ID: 18449015
    [No Abstract]   [Full Text] [Related]  

  • 2. Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea.
    Mizota A; Shitara K; Fukui T
    J Thorac Oncol; 2011 Mar; 6(3):651-2. PubMed ID: 21317750
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of pulmonary epithelioid hemangioendothelioma with bevacizumab.
    Kim YH; Mishima M; Miyagawa-Hayashino A
    J Thorac Oncol; 2010 Jul; 5(7):1107-8. PubMed ID: 20581581
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multicentric epithelioid hemangioendothelioma involving lung, mediastinum and liver].
    Maamouri F; Ennaifer Jerbi E; Tounsi Guettiti H; Boussen H; Dellagi K; Boubaker S
    Tunis Med; 2008 Jun; 86(6):616-7. PubMed ID: 19216465
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multifocal epithelioid haemangioendothelioma].
    Hassan Osman M; Mehiri N; Chérif J; Zouaoui A; Toujani S; Louzir B; Haouet S; Menif E; Doghfous J; Béji M
    Tunis Med; 2009 Sep; 87(9):637. PubMed ID: 20180390
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bevacizumab and lung cancer: eligible patients in daily practice].
    Lagnien-Gaume V; Jehl J; Manzoni P; Jacoulet P; Gainet-Brun M; Metzger F; Pernet D; Polio JC; Pugin JF; Corgne J; Amoros C; Dalphin JC; Westeel V
    Rev Mal Respir; 2011 Jan; 28(1):25-31. PubMed ID: 21277471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
    Sandler A; Gray R; Perry MC; Brahmer J; Schiller JH; Dowlati A; Lilenbaum R; Johnson DH
    N Engl J Med; 2006 Dec; 355(24):2542-50. PubMed ID: 17167137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab for recurrent hemangioendothelioma.
    Trautmann K; Bethke A; Ehninger G; Folprecht G
    Acta Oncol; 2011 Jan; 50(1):153-4. PubMed ID: 20950228
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy.
    Pinet C; Magnan A; Garbe L; Payan MJ; Vervloet D
    Eur Respir J; 1999 Jul; 14(1):237-8. PubMed ID: 10489858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic hepatic epithelioid hemangioendothelioma in a teenage girl.
    Kassam A; Mandel K
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):550-2. PubMed ID: 18797205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and tolerance of bevacizumab in non-small cell lung cancer: preliminary report].
    Mazières J; Dansin E
    Rev Pneumol Clin; 2008 Aug; 64(4):166-72. PubMed ID: 19019283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary pleural epithelioid hemangioendothelioma compressing the myocardium.
    Yu L; Gu T; Xiu Z; Shi E; Zhao X
    J Card Surg; 2013 May; 28(3):266-8. PubMed ID: 23551388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracheo-esophageal fistula with bevacizumab after mediastinal radiation.
    Goodgame B; Veeramachaneni N; Patterson A; Govindan R
    J Thorac Oncol; 2008 Sep; 3(9):1080-1. PubMed ID: 18758321
    [No Abstract]   [Full Text] [Related]  

  • 14. Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options.
    Semenisty V; Naroditsky I; Keidar Z; Bar-Sela G
    BMC Cancer; 2015 May; 15():402. PubMed ID: 25967676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of bevacizumab for the treatment of non-small-cell lung cancer.
    Ramalingam S; Belani CP
    Future Oncol; 2007 Apr; 3(2):131-9. PubMed ID: 17381412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer: an evidence-based approach.
    Tassinari D; Sartori S; Papi M; Drudi F; Castellani C; Carloni F; Tombesi P; Lazzari-Agli L
    Oncology; 2011; 80(5-6):350-8. PubMed ID: 21791945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab in breast cancer: the best is yet to come?
    Puhalla S; Brufsky A
    Oncology (Williston Park); 2009 Apr; 23(4):332, 335. PubMed ID: 19476262
    [No Abstract]   [Full Text] [Related]  

  • 18. Bronchoesophageal fistula and fatal hemoptysis after bevacizumab-containing chemotherapy without radiation in lung cancer.
    Schreiber J; Waldburg N
    J Clin Oncol; 2012 Nov; 30(32):e324. PubMed ID: 23008311
    [No Abstract]   [Full Text] [Related]  

  • 19. Bevacizumab and recurrent malignant gliomas: a European perspective.
    Wick W; Weller M; van den Bent M; Stupp R
    J Clin Oncol; 2010 Apr; 28(12):e188-9; author reply e190-2. PubMed ID: 20159801
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.
    Crinò L; Dansin E; Garrido P; Griesinger F; Laskin J; Pavlakis N; Stroiakovski D; Thatcher N; Tsai CM; Wu YL; Zhou C
    Lancet Oncol; 2010 Aug; 11(8):733-40. PubMed ID: 20650686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.